CONSTANT INNOVATION
IN
LIFE SCIENCES
CONSTANT INNOVATION IN
LIFE SCIENCES
How We Work
The Life Sciences industry thrives on constant innovation. But navigating complex regulations, optimizing R&D processes, and ensuring efficient go-to-market strategies can be a challenge. At AEACGi, we offer a comprehensive suite of consulting services designed to empower your life science organization. We support you all the way from the early stages of the R&D process to the best commercialization strategy. We are bringing you all the industry good practices as well as the technology disruptors to increase your operational efficiency.
Industry Challenge
LifeSciences traditionally relied on a traditional B2B ecommerce platform that offered a generic user experience and limited functionality. This resulted in several challenges:
- Regulatory Compliance Regulatory bodies at Federal and Provincial level maintain stringent criterial for any new medical solution adds to the layer of complexity. Any deviation leads to costly delays with no reimbursement
- Complex Supply Chains Due to nature of various drugs that needs to be shipped in a timely manner to preserve the efficacy of drug, a routine supply chain doesn’t necessarily meet the needs of this industry.
- Time to Market Delay Competitiveness and market demand has put more pressure on Life Sciences to streamline their clinical trials records and insights to launch the product in a timely manner.
- Intellectual Property Concerns The backbone of life sciences is to get patent on their innovations for ensuring a return on investment. IPR also differs geographically which elevates the risk of dispute and generic brands.
- Clinical Trials A long battle between ethical vs non-ethical clinical trials on animals vs humans puts more pressure on this industry on making that balance.
- Research and Development Costs R&D costs have gone to the roof as more stringent rules are being enforced. Pressure from the market, time to launch with effectiveness are some of the factors that contribute majorly to the cost.
- Market Access and Reimbursements Costs Organizations must demonstrate the clinical and economic value of their products to payers, insurers, and healthcare providers, which requires robust evidence generation and health economic analyses.
Solutions
A world leading distributor (Germany) of specialized laboratory equipment and reagents for the life science research community…